Form 4: BorgWarner VP Sells 2,500 Shares Under 10b5-1 Plan

BorgWarner Vice President Isabelle McKenzie sold 2,500 shares of common stock for approximately $40.01 per share on August 12, 2025, as part of a pre-arranged trading plan.

Summary

• Isabelle McKenzie, Vice President of BorgWarner Inc. (BWA), reported the sale of 2,500 shares of common stock.
• The transaction occurred on August 12, 2025, at a weighted average price of $40.0101 per share.
• The actual prices received for the shares ranged from $40.0101 to $40.0110.
• Following this transaction, Ms. McKenzie beneficially owns 55,945 shares of BorgWarner common stock.
• The sale was executed pursuant to a Rule 10b5-1(c) contract, instruction, or written plan for the purchase or sale of equity securities.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a routine, pre-scheduled insider stock sale under a 10b5-1 plan, which is a common practice for executives managing their personal portfolios.

Positives

• The transaction was conducted under a Rule 10b5-1(c) plan, indicating a pre-scheduled sale rather than a reaction to immediate, non-public information, which enhances transparency and reduces concerns about opportunistic insider trading.

Negatives

• An officer's sale of shares, even if pre-planned, reduces their direct equity stake in the company.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This Form 4 filing reports a routine insider transaction and does not provide information directly related to broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: May view the sale as a minor, routine event, especially given the 10b5-1 plan, with minimal impact on their investment decisions.

Key Dates

Recommendation

This Form 4 reports a routine, pre-scheduled sale of a relatively small number of shares by a Vice President under a 10b5-1 plan. Such a transaction is generally not indicative of a significant change in the company's fundamentals or future prospects and therefore does not warrant a change in investment recommendation based solely on this filing. Investors should continue to evaluate BorgWarner based on its broader financial performance, strategic initiatives, and market conditions.

Keywords

BORGWARNER, BWA, Insider Trading, Form 4, Stock Sale, Executive Transaction, 10b5-1 Plan